Status:
UNKNOWN
Neurofeedback Study ADHD
Lead Sponsor:
Philipps University Marburg
Conditions:
ADHD
Eligibility:
All Genders
7-11 years
Phase:
PHASE2
Brief Summary
Neurofeedback has proved to be effective in treating Attention deficit hyperactivity disorder (ADHD) in experimental settings. This study investigates whether neurofeedback can be used as a therapeuti...
Eligibility Criteria
Inclusion
- children with ADHD aged 7 to 11
- full command of the German language.
Exclusion
- IQ below 80
- Children with symptoms of:
- inattention,
- hyperactivity or
- impulsivity due to other medical reasons such as:
- hyperthyreosis,
- autism,
- epilepsy,
- brain disorders and
- any genetic or medical disorder associated with externalizing behavior that mimics ADHD.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01879644
Start Date
January 1 2011
End Date
December 1 2018
Last Update
November 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philipps-University Marburg, Department of Psychology, Clinical Child and Adolescent Psychology
Marburg, Hesse, Germany, 35037